SparingVision Announces Upcoming Poster Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2021 Virtual Annual Meeting
An abstract on rod-derived cone viability factor (RdCVF) in pig models of Retinitis Pigmentosa (RP)…
New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital with additional investment…
Paris, June 30th, 2020 – SparingVision, a biotechnology company specializing in the research and development…